Literature DB >> 23440973

Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis.

Anita Mahadevan1, Arvinda Hanumantapura Ramalingaiah, Satishchandra Parthasarathy, Avindra Nath, Udaykumar Ranga, Shankar Susarla Krishna.   

Abstract

Cerebral toxoplasmosis is a frequent cause of focal brain lesions in the setting of immunodeficiency states, particularly acquired immune deficiency syndrome (AIDS), and magnetic resonance imaging (MRI) is an important diagnostic modality to differentiate toxoplasmosis from tuberculoma, and primary central nervous system lymphoma with diverse therapeutic implications. Several imaging patterns have been described in cerebral toxoplasmosis. The "concentric target sign" is a recently described MRI sign on T2-weighted imaging of cerebral toxoplasmosis that has concentric alternating zones of hypo- and hyperintensities. It is believed to be more specific than the well-known "eccentric target sign" in the diagnosis of cerebral toxoplasmosis and hence more useful in differentiation from other focal brain lesions in the context of AIDS. The concentric target sign, seen in deep parenchymal lesions, is distinct from the surface-based cortical "eccentric" target sign. The histopathological correlate of the latter has been recently described, but that of the concentric target sign is not known. In this study we describe the neuropathological correlate of this concentric target sign from the postmortem of a 40-year-old man with AIDS-associated cerebral toxoplasmosis. The concentric alternating zones of hypo/hyper/iso/intensities corresponded to zones of hemorrhage/fibrin-rich necrosis with edema/coagulative compact necrosis/inflammation with foamy histiocytes admixed with hemorrhage forming the outermost zone, respectively. The exclusive specificity of this sign in cerebral toxoplasmosis remains to be further elucidated.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  AIDS; MRI; T2 WI; concentric target sign; neuropathology; toxoplasmosis

Mesh:

Year:  2013        PMID: 23440973      PMCID: PMC4442780          DOI: 10.1002/jmri.24036

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  27 in total

1.  SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS.

Authors:  D J Skiest; W Erdman; W E Chang; O K Oz; A Ware; J Fleckenstein
Journal:  J Infect       Date:  2000-05       Impact factor: 6.072

2.  Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.

Authors:  Constance A Benson; Jonathan E Kaplan; Henry Masur; Alice Pau; King K Holmes
Journal:  MMWR Recomm Rep       Date:  2004-12-17

3.  Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96).

Authors:  P Satishchandra; A Nalini; M Gourie-Devi; N Khanna; V Santosh; V Ravi; A Desai; A Chandramuki; P N Jayakumar; S K Shankar
Journal:  Indian J Med Res       Date:  2000-01       Impact factor: 2.375

4.  Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature.

Authors:  G G Sharath Kumar; A Mahadevan; A S Guruprasad; Jerry M E Kovoor; P Satishchandra; Avindra Nath; Udaykumar Ranga; S K Shankar
Journal:  J Magn Reson Imaging       Date:  2010-06       Impact factor: 4.813

5.  Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosis.

Authors:  Andrew Kong; Adam Koukourou; Mark Boyd; George Crowe
Journal:  J Clin Neurosci       Date:  2006-11       Impact factor: 1.961

6.  Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma.

Authors:  Mohammad Wasay; Bhojo A Kheleani; Mahesh K Moolani; Jazia Zaheer; Margaret Pui; Sheema Hasan; Suhail Muzaffar; Rohit Bakshi; Arif R Sarawari
Journal:  J Neuroimaging       Date:  2003-07       Impact factor: 2.486

7.  Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka.

Authors:  P Sundar; A Mahadevan; R S Jayshree; D K Subbakrishna; S K Shankar
Journal:  Indian J Med Res       Date:  2007-07       Impact factor: 2.375

Review 8.  Cerebral toxoplasmosis: case review and description of a new imaging sign.

Authors:  R Masamed; A Meleis; E W Lee; G M Hathout
Journal:  Clin Radiol       Date:  2009-01-25       Impact factor: 2.350

9.  Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.

Authors:  Nagadenahalli B Siddappa; Prashanta K Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa S Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; Vasanthapuram Ravi; Susarla K Shankar; Raj Shankarappa; Udaykumar Ranga
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  10 in total

Review 1.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

Review 2.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

3.  Thrombotic complications and tip position of transjugular chronic dialysis catheter scheduled into superior vena cava: Findings on HR-MRCP and HR-T2WI.

Authors:  Whenzheng Li; Fang Li; He Wang; Xueying Long; Obin Ghimire; Yigang Pei; Xiangcheng Xiao; Jianping Ning
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

4.  Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Toxoplasma gondii infection: A case report.

Authors:  Xiaotang Cai; Hui Zhou; Yongmei Xie; Dan Yu; Zhiling Wang; Haitao Ren
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

5.  Concentric and Eccentric Target MRI Signs in a Case of HIV-Associated Cerebral Toxoplasmosis.

Authors:  Adam D Roche; Dominic Rowley; Francesca M Brett; Seamus Looby
Journal:  Case Rep Neurol Med       Date:  2018-02-21

Review 6.  HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.

Authors:  José Ernesto Vidal
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

7.  Fulminant and Diffuse Cerebral Toxoplasmosis as the First Manifestation of HIV Infection: A Case Presentation and Review of the Literature.

Authors:  Salman Abbasi Fard; Ali Khajeh; Alireza Khosravi; Afsaneh Mirshekar; Safoora Masoumi; Farhad Tabasi; Tania Hassanzadeh; Martin M Mortazavi
Journal:  Am J Case Rep       Date:  2020-01-26

8.  CNS Lymphoma: Clinical Pearls and Management Considerations.

Authors:  Michelot Michel; Noelle Lucke-Wold; Mohammad Reza Hosseini; Eric Panther; Ramya Reddy; Brandon Lucke-Wold
Journal:  Biomed Res Clin Rev       Date:  2022-06-27

Review 9.  MRI imaging features of HIV-related central nervous system diseases: diagnosis by pattern recognition in daily practice.

Authors:  Mio Sakai; Masahiro Higashi; Takuya Fujiwara; Tomoko Uehira; Takuma Shirasaka; Katsuyuki Nakanishi; Nobuo Kashiwagi; Hisashi Tanaka; Hitoshi Terada; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2021-06-14       Impact factor: 2.374

10.  Audit of computed tomography brain findings in HIV-infected patients with space occupying infective lesions at a regional level hospital in KwaZulu-Natal.

Authors:  Somasundram Pillay; Kaveer Ramchandre
Journal:  SAGE Open Med       Date:  2018-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.